- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Impact of Group Purchasing Organizations on Healthcare Prices
Who sets the price for medications and other supplies used in hospitals and why are there shortages of some of these items? Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center as well as executive director of Choosing Wisely, discussed this issue and its ramifications for healthcare costs.
Who sets the price for medications and other supplies used in hospitals and why are there shortages of some of these items? Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center, along with 2 co-authors, discussed this issue in a recent article in JAMA called Group Purchasing Decisions, Health Care Costs, and Drug Shortages.
Makary is a clinical lead for the Johns Hopkins Sibley Innovation Hub and is executive director of Choosing Wisely, a Robert Wood Johnson Foundation project to lower healthcare costs in the United States by creating measures of appropriateness in healthcare. He serves jointly as a professor of surgery at the Johns Hopkins University School of Medicine and a professor of health policy and management at the Johns Hopkins Bloomberg School of Public Health.
His latest book, The Price We Pay: What Broke American Health Care—And How to Fix It—is scheduled for release in 2019.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss?rel=0" ?rel=0"
TuneIn: http://bit.ly/2gv7iwj?rel=0" ?rel=0"
Stitcher: http://bit.ly/2gCqtFg?rel=0" ?rel=0"
Listen to a previous episode of Managed Care Cast, when Makary discussed the ethics of hospital markups, or read his research about that topic in The American Journal of Managed Care® (AJMC®).
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
